Proxygen and Merck collaborates to develop molecular glue degraders
The companies will jointly identify and develop molecular glue degraders up to a clinical candidate stage.
The companies will jointly identify and develop molecular glue degraders up to a clinical candidate stage.
Immune-mediated events and infusion reactions were higher with KEYTRUDA (38% vs 9%, respectively).
Report lays out blueprint for achieving Organon’s purpose and business imperatives to help women and girls achieve their promise through better health
The new Oncology CRO will aim to drive faster execution and higher quality trial outcomes for Oncology sponsors.
As per partnership, Carbanio will arrange raw materials and other custom chemicals for Proexp Pharma Pvt. Ltd. through an uninterrupted digital process of the company
PAYBACK loyalty will be live in 4500 Apollo Pharmacy outlets across India
Dr Jitendra Singh said, the Biotech Park would act as a hub for incubation of new ideas
The ABDM public dashboard is a one-stop solution for information on the mission’s progress up to state/UT level
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
Subscribe To Our Newsletter & Stay Updated